SEC EDGAR Filing Information

Form 3 -- Initial statement of beneficial ownership of securities

Period of Report: 2008-08-05
Filing Date Changed: 2008-08-07
Documents: 2
SEC Accession No.
0000932440-08-000499
Filing date: 2008-08-07
Accepted: 2008-08-07 17:04:13

Table of submitted documents:

Seq Type Document Size Description
1 3 edgar.html PRIMARY DOCUMENT
1 3 edgar.xml 5769 PRIMARY DOCUMENT
2 EX-24 exh24-1_1277840.htm 10262 POWER OF ATTORNEY
0000932440-08-000499.txt 18636 Complete submission text file

Filer Information:

AVANIR PHARMACEUTICALS (Issuer) (0000858803)
IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656
949-389-6700
 Mailing Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656

Moorin Jay (Reporting) (0001033508)
IRS No.: | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-15803 | Film No.: 08999400
Business Address
C/O PROQUEST INVESTMENTS, L.P.
600 ALEXANDER PARK
SUITE 204 NJ 08540
6099193567
 Mailing Address
C/O PROQUEST INVESTMENTS, L.P
90 NASSAU STREET, 5TH FLOOR
PRINCETON NJ 08542

SCHREIBER ALAIN (Reporting) (0001225149)
Type: 3 | Act: 34 | File No.: 001-15803 | Film No.: 08999401
Business Address
6099193567
 Mailing Address
90 NASSAU STREET
5TH FLOOR
PRINCETON NJ 08542